These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species. Fass RJ. Antimicrob Agents Chemother; 1981 Feb; 19(2):361-3. PubMed ID: 6289732 [Abstract] [Full Text] [Related]
3. Sch 29482: activity against susceptible and beta-lactam resistant variants of Enterobacteriaceae. Chabbert YA, Jaffé A. J Antimicrob Chemother; 1982 Feb; 9 Suppl C():203-12. PubMed ID: 6977531 [No Abstract] [Full Text] [Related]
4. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae. Watkins RR, Deresinski S. Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107 [No Abstract] [Full Text] [Related]
5. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition. Jones RN, Barry AL, Fuchs PC, Thornsberry C. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606 [Abstract] [Full Text] [Related]
6. beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae. Mouton RP, Mulders SL, van Gestel MH. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():111-7. PubMed ID: 3928576 [Abstract] [Full Text] [Related]
8. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae. Romero E, Pagani L, Perduca M, Mignatti P, Malfa S, Mills V. Microbiologica; 1984 Jul; 7(3):209-18. PubMed ID: 6334220 [Abstract] [Full Text] [Related]
9. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343. Neu HC, Chin NX, Labthavikul P. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603 [Abstract] [Full Text] [Related]
10. Indication of Minimum Inhibitory Concentration of β-Lactam Antimicrobials for the Primary Extraction of IMP-Producing Enterobacteriaceae. Saito K, Nakamura K, Harada R, Nakano R, Yano H, Kanemitsu K. Jpn J Infect Dis; 2019 Jan 23; 72(1):68-70. PubMed ID: 30381689 [No Abstract] [Full Text] [Related]
11. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability. Stobberingh EE, Houben AW, van Boven CP. J Antimicrob Chemother; 1985 Jun 23; 15 Suppl C():73-83. PubMed ID: 3875605 [Abstract] [Full Text] [Related]
12. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. Medeiros AA, Hare R, Papa E, Adam C, Miller GH. J Antimicrob Chemother; 1985 Jun 23; 15 Suppl C():119-32. PubMed ID: 3875602 [Abstract] [Full Text] [Related]
13. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins. Betriu C, Salso S, Sánchez A, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ. Int J Antimicrob Agents; 2006 Jul 23; 28(1):1-5. PubMed ID: 16769202 [Abstract] [Full Text] [Related]
20. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain. Colom K, Fernández-Aranguiz A, Alonso R, Suinaga E, Cisterna R. Microb Drug Resist; 1996 Jul 23; 2(3):353-9. PubMed ID: 9158795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]